Abstract
Gene-based in vivo electroporation has the potential to be used as a “protein-free” method to elicit immune responses and to generate monoclonal antibodies (mAb) against proteins/peptides in hosts. However, the method is very useful to raise mAbs against proteins and peptides and not for carbohydrates, lipids, or haptens. Nevertheless, making mAb using this potent method faces a few challenges: the parameters of the electroporation needs further standardized, the final boost still needs protein antigens, and the primary screening of the clones requires purified protein. We present methods to overcome these challenges by an optimized electroporation framework and a method to use transiently transfected cells for the final boost, as well as for screening of the resulting clones via the use of an “In-Cell Western” method.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Daftarian P, Chowdhury R, Ames P et al (2011) In vivo electroporation and non-protein based screening assays to identify antibodies against native protein conformations. Hybridoma 30:409–418
Wei CJ, Boyington JC, McTamney PM et al (2010) Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329:1060–1064
André F, Mir LM (2004) DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther 11(Suppl 1): S33–42
Cantelli CP, Da Glória Martins Teixeira M, Santos EA et al (2009) Generation of monoclonal antibodies against human recombinant interferon beta using genetic immunization with simultaneous expression of IgM and IgG isotypes. Hybridoma 28:211–214
Chua KY, Ramos JDA, Cheong N (2008) Production of monoclonal antibody by DNA immunization with electroporation. Methods Mol Biol 423:509–520
Ahmad S, Casey G, Sweeney P, Tangney M, O’Sullivan GC (2010) Optimised electroporation mediated DNA vaccination for treatment of prostate cancer. Genetic vaccines Ther 8:1
Howarth M, Elliott T (2004) The processing of antigens delivered as DNA vaccines. Immunol Rev 199:27–39
Kong WP, Hood C, Yang Z-Y et al (2006) Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination. Proc Natl Acad Sci U S A 103:15987–15991
Chu THT, Yazdanbakhsh K, Oyen R, Smart E, Reid ME (1999) Production and characterization of anti-Kell monoclonal antibodies using transfected cells as the immunogen. Br J Haematol 106:817–823
Buchan S, Gronevik E, Mathiesen I, King CA, Stevenson FK, Rice J (2005) Electroporation as a “prime/boost” strategy for naked dna vaccination against a tumor antigen. J Immunol 174:6292–6298
Kay Bates M, Zhang G, Sebestyén M, Neal Z, Wolff J, Herweijer H (2006) Genetic immunization for antibody generation in research animals by intravenous delivery of plasmid DNA. Biotechniques 40:199–208
Möller S, Jung C, Adriouch S et al (2007) Monitoring the expression of purinoceptors and nucleotide-metabolizing ecto-enzymes with antibodies directed against proteins in native conformation. Purinergic Signal 3:359–366
Selkirk JV, Nottebaum LM, Ford IC, Santos M, Malany S, Foster AC, Lechner SM (2006) A novel cell-based assay for G-protein-coupled receptor-mediated cyclic adenosine monophosphate response element binding protein phosphorylation. J Biomol Screen 11: 351–358
Hlavin ML, Lemmon V (1991) Molecular structure and functional testing of human L1CAM: an interspecies comparison. Genomics 11:416–423
Roos AK, Eriksson F, Timmons JA et al (2009) Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment. PLoS One 4:e7226
Feng H, Sun Z, Farzan MR, Feng P (2010) Sulfotyrosines of the Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor promote tumorigenesis through autocrine activation. J Virol 84:3351–3361
Acknowledgement
This experiment of Fig. 1 and the figure was performed by Drs. M. Giel-Moloney and K Pugachev, Sanofi Pasteur.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Daftarian, M.P., Vosoughi, A., Lemmon, V. (2014). Gene-Based Vaccination and Screening Methods to Develop Monoclonal Antibodies. In: Li, S., Cutrera, J., Heller, R., Teissie, J. (eds) Electroporation Protocols. Methods in Molecular Biology, vol 1121. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-9632-8_30
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9632-8_30
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4614-9631-1
Online ISBN: 978-1-4614-9632-8
eBook Packages: Springer Protocols